Compare ELLO & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELLO | NUS |
|---|---|---|
| Founded | 1987 | 1984 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Other Pharmaceuticals |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.1M | 343.1M |
| IPO Year | 1998 | 1996 |
| Metric | ELLO | NUS |
|---|---|---|
| Price | $25.00 | $7.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.2K | ★ 362.1K |
| Earning Date | 03-31-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | N/A | ★ 3.18 |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.14 |
| P/E Ratio | ★ N/A | $2.22 |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $13.21 | $5.65 |
| 52 Week High | $30.34 | $14.62 |
| Indicator | ELLO | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 48.37 | 44.13 |
| Support Level | $24.11 | $7.03 |
| Resistance Level | $25.70 | $8.08 |
| Average True Range (ATR) | 1.05 | 0.23 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 30.56 | 23.94 |
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.